Advertisement

Topics

Oxford Uni collaboration Scenic Biotech secures funding for its 'genetic off-switch'

06:55 EDT 6 Jun 2017 | Pharmafile

The University of Oxford has joined forces with the Netherlands Cancer Institute (NKI) in an international collaboration known as Scenic Biotech, which aims to tackle cancer and other diseases on a genetic level.

read more

Original Article: Oxford Uni collaboration Scenic Biotech secures funding for its 'genetic off-switch'

NEXT ARTICLE

More From BioPortfolio on "Oxford Uni collaboration Scenic Biotech secures funding for its 'genetic off-switch'"

Quick Search
Advertisement
 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...